Old Web
English
Sign In
Acemap
>
authorDetail
>
Zeshen Wu
Zeshen Wu
Axitinib
Oncology
Medicine
Renal cell carcinoma
Immunotherapy
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Neoadjuvant combination of pazopanib or axitinib and programmed cell death protein-1-activated dendritic cell-cytokine-induced killer cells immunotherapy may facilitate surgery in patients with renal cell carcinoma
2021
Translational Andrology and Urology
Zhiling Zhang
Long-Bin Xiong
Zeshen Wu
Huiming Liu
Kang Ning
Yulu Peng
Chunping Yu
Ya Ding
Desheng Weng
Jianchuan Xia
Lijuan Jiang
Shengjie Guo
Hui Han
Fangjian Zhou
Pei Dong
Show All
Source
Cite
Save
Citations (0)
MP14-18 NEOADJUVANT COMBINATION OF PAZOPANIB OR AXITINIB AND PD-1-ACTIVATED DC-CIK CELLS IMMUNOTHERAPY MAY FACILITATE SURGERY IN PATIENTS WITH RENAL CELL CARCINOMA
2021
The Journal of Urology
Longbin Xiong
Zeshen Wu
Pei Dong
Huiming Liu
Kang Ning
Yulu Peng
Chunping Yu
Ya Ding
Desheng Weng
Jianchuan Xia
Lijuan Jiang
Shengjie Guo
Hui Han
Fangjian Zhou
Zhiling Zhang
Show All
Source
Cite
Save
Citations (0)
1